Imaging for Headaches and Neurological Symptoms

Neurological imaging encompasses the use of radiological studies — primarily CT and MRI — to evaluate headaches, stroke, seizures, cognitive decline, and other disorders affecting the brain, spine, and peripheral nervous system. Understanding which modality applies to which clinical scenario is essential to accurate diagnosis and appropriate resource use. This page covers the defining scope of neurological imaging, how individual modalities function in this context, the clinical scenarios that prompt imaging orders, and the decision boundaries that separate necessary from unnecessary studies.

Definition and scope

Neurological imaging refers to structured radiological evaluation of the central and peripheral nervous system, including the brain, brainstem, cerebellum, spinal cord, and cranial and spinal vasculature. The American College of Radiology (ACR) maintains the ACR Appropriateness Criteria, a publicly available evidence-based framework that defines which imaging modalities are appropriate for 39 neurological clinical variants, ranging from acute-onset headache to suspected dementia.

The scope of neurological imaging is broad because the symptom burden is high: headache alone accounts for more than 1 in 20 emergency department visits in the United States, according to the CDC National Hospital Ambulatory Medical Care Survey. Not all of those encounters warrant imaging, but a clinically meaningful subset involves pathology — hemorrhage, mass lesion, infarct, or demyelination — that imaging can detect before it causes irreversible harm.

As a foundation for understanding how imaging decisions fit into broader radiology practice, the radiologyauthority.com site index provides orientation across all major imaging domains.

How it works

Two modalities dominate neurological imaging: computed tomography (CT) and magnetic resonance imaging (MRI). Each operates on different physical principles and produces different diagnostic yields depending on the clinical question.

CT uses ionizing X-ray beams rotated around the patient and reconstructed by computer into cross-sectional images. In the neurological context, non-contrast head CT is the standard first-line tool in emergencies because it is fast (acquisition in under 2 minutes on modern scanners), widely available around the clock, and highly sensitive to acute intracranial hemorrhage. CT angiography (CTA), performed with intravenous iodinated contrast, adds vascular detail sufficient to identify aneurysms, arteriovenous malformations, and large-vessel occlusions in acute stroke triage.

MRI uses magnetic fields and radiofrequency pulses to produce tissue contrast far superior to CT for soft-tissue differentiation. Key MRI sequences in neurological imaging include:

1. Diffusion-weighted imaging (DWI) — detects acute ischemic stroke within minutes of onset by identifying restricted water diffusion in infarcted tissue.
2. FLAIR (Fluid-Attenuated Inversion Recovery) — suppresses cerebrospinal fluid signal to reveal periventricular white matter lesions, a hallmark of multiple sclerosis.
3. T1 with gadolinium contrast — identifies blood-brain barrier breakdown, which occurs in tumors, active demyelinating plaques, and abscess.
4. Susceptibility-weighted imaging (SWI) — detects microhemorrhages and cerebral amyloid angiopathy deposits invisible on standard sequences.
5. MR angiography (MRA) — visualizes intracranial vessels without ionizing radiation, useful for aneurysm surveillance.

MRI typically requires 20–60 minutes of scanner time and is incompatible with certain metallic implants. The safety framework governing implant compatibility is detailed under MRI safety.

Common scenarios

Acute-onset "thunderclap" headache — Sudden-onset headache reaching peak intensity within 60 seconds is treated as subarachnoid hemorrhage (SAH) until proven otherwise. Non-contrast CT head is performed first; if negative, lumbar puncture follows to detect xanthochromia. CT sensitivity for SAH is approximately 98% within the first 6 hours of onset but declines substantially beyond 24 hours (ACR Appropriateness Criteria, Headache — Sudden Onset Severe).

Acute ischemic stroke — The 2018 AHA/ASA stroke guidelines (Stroke, 2018;49:e46–e110) establish CT without contrast as the minimum imaging requirement before thrombolysis, with CTA of the head and neck added when large-vessel occlusion is suspected for mechanical thrombectomy evaluation. MRI with DWI is preferred when time allows, given superior sensitivity for small cortical and posterior fossa infarcts.

New or progressive neurological deficit — MRI with and without contrast is the preferred modality for evaluating brain or spinal cord lesions responsible for focal deficits, including tumors, demyelinating plaques, or compressive myelopathy.

Chronic or recurrent headache — The vast majority of migraine and tension-type headaches do not require imaging. The ACR and the American Headache Society both indicate that imaging in uncomplicated migraine with a stable pattern and normal neurological examination is unlikely to yield clinically significant findings. Imaging becomes appropriate when headaches change in character, are associated with neurological signs, occur in patients older than 50 without prior headache history, or are provoked by Valsalva maneuver.

Seizures — First-time unprovoked seizure in an adult warrants MRI with contrast to exclude structural etiology. The American College of Radiology Appropriateness Criteria for Seizures rates MRI brain without and with contrast as "usually appropriate" for new-onset seizure.

Decision boundaries

The regulatory and clinical framework governing imaging appropriateness in neurology rests primarily on the ACR Appropriateness Criteria, which assign ratings of "usually appropriate," "may be appropriate," or "usually not appropriate" to each modality-scenario pairing. The regulatory context for radiology outlines how CMS, The Joint Commission, and ACR standards interact to shape imaging utilization practices at the institutional level.

Three structural decision boundaries separate indicated from non-indicated neurological imaging:

• Red flag features present: Sudden maximal headache, papilledema, fever with meningismus, focal neurological deficit, altered consciousness, or new headache in an immunocompromised or oncology patient — all trigger imaging without deferral.
• Stable, benign clinical pattern: Longstanding migraine with unchanged character, normal neurological exam, and no systemic illness — imaging is generally not indicated on a routine basis.
• Age and risk stratification: Patients over 50 presenting with new headache type, and any patient with known malignancy presenting with new neurological symptoms, shift toward "usually appropriate" imaging regardless of headache acuity.

CT versus MRI selection is governed by clinical urgency, contraindication profile, and the anatomical region in question. Posterior fossa pathology — cerebellar infarct, fourth-ventricular obstruction — is poorly visualized on CT due to beam-hardening artifact from surrounding bone; MRI is the definitive modality for that region. Conversely, acute bone injury, calcification, and hemorrhage within the first hours favor CT. The modality comparison at how medical imaging works provides additional technical grounding for these distinctions.

References

• ACR Appropriateness Criteria — Neurology — American College of Radiology
• 2018 AHA/ASA Guidelines for Early Management of Acute Ischemic Stroke — American Heart Association / American Stroke Association
• CDC National Hospital Ambulatory Medical Care Survey — Centers for Disease Control and Prevention
• ACR Appropriateness Criteria — Seizures — American College of Radiology
• American Headache Society Evidence-Based Guidelines — American Headache Society

The law belongs to the people. Georgia v. Public.Resource.Org, 590 U.S. (2020)